Investor Presentaiton slide image

Investor Presentaiton

Chronic Therapies Acute Therapies Secondary Sales Performance Market beating performance across major therapeutic segments in Q2FY23 Market rank Market rank Anti-infectives 7.8% 7.2% | Alkem sales growth YoY1,2 17 Anti-diabetic 29.5% 2 Gastro-intestinal 22.7% Pain/ Analgesics 19.2% Vitamins/Minerals / Nutrients 12.5% 11.6% 11.5% 6.4% 8 Neuro/ CNS 7.8% 9.8% 5.4% Indian pharma industry sales growth YoY1,2 -1.4% 28 Cardiac 17 Derma 10.1% 4.5% 0.1% Alkem sales growth YoY1,2 Source: IQVIQ data 1 Domestic formulations sales; 2 For 3 months ended September 30, 2022 Indian pharma industry sales growth YoY1,2
View entire presentation